Viveve Medical's market value is the price at which a share of Viveve Medical trades on a public exchange. It measures the collective expectations of Viveve Medical investors about its performance. Viveve Medical is trading at 2.0E-4 as of the 11th of February 2026, a 33.33 percent decrease since the beginning of the trading day. The stock's lowest day price was 2.0E-4. With this module, you can estimate the performance of a buy and hold strategy of Viveve Medical and determine expected loss or profit from investing in Viveve Medical over a given investment horizon. Check out Viveve Medical Correlation, Viveve Medical Volatility and Viveve Medical Performance module to complement your research on Viveve Medical.
Please note, there is a significant difference between Viveve Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Viveve Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Viveve Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Viveve Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Viveve Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Viveve Medical.
0.00
11/13/2025
No Change 0.00
0.0
In 3 months and 1 day
02/11/2026
0.00
If you would invest 0.00 in Viveve Medical on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Viveve Medical or generate 0.0% return on investment in Viveve Medical over 90 days. Viveve Medical is related to or competes with Gilead Sciences, Sanofi ADR, Amgen, Merck, and Novo Nordisk. Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for t... More
Viveve Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Viveve Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Viveve Medical upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Viveve Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Viveve Medical's standard deviation. In reality, there are many statistical measures that can use Viveve Medical historical prices to predict the future Viveve Medical's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Viveve Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Viveve Medical is out of control given 3 months investment horizon. Viveve Medical owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.17, which indicates the firm had a 0.17 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for eighteen different technical indicators, which can help you to evaluate if expected returns of 27.69% are justified by taking the suggested risk. Use Viveve Medical Risk Adjusted Performance of 0.1054, coefficient of variation of 838.38, and Variance of 10042.02 to evaluate company specific risk that cannot be diversified away. Viveve Medical holds a performance score of 13 on a scale of zero to a hundred. The entity has a beta of 6.92, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Viveve Medical will likely underperform. Use Viveve Medical variance, as well as the relationship between the kurtosis and period momentum indicator , to analyze future returns on Viveve Medical.
Auto-correlation
0.11
Insignificant predictability
Viveve Medical has insignificant predictability. Overlapping area represents the amount of predictability between Viveve Medical time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Viveve Medical price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Viveve Medical price fluctuation can be explain by its past prices.
Correlation Coefficient
0.11
Spearman Rank Test
0.82
Residual Average
0.0
Price Variance
0.0
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Viveve Pink Sheet
Viveve Medical financial ratios help investors to determine whether Viveve Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Viveve with respect to the benefits of owning Viveve Medical security.